Skip to main content
. Author manuscript; available in PMC: 2017 Apr 19.
Published in final edited form as: Adv Funct Mater. 2016 Feb 1;26(15):2512–2522. doi: 10.1002/adfm.201504879

Figure 7.

Figure 7

Concentration of OVA-specific lgG (left pannel) and lgA (right pannel) at 4 weeks after laser adjuvant (l.a.) and topical application of HA-OVA conjugates with various doses (mean ± SD, n = 4), in comparison to intramuscular (i.m.) injection and transdermal (t.d.) application without laser adjuvants. ***, P < 0.001.